NHP adverse reaction reporting in Canada is one of the post-market obligations most new brand owners overlook, and it carries real regulatory weight. Once your natural health product is on shelves, Health Canada expects you to track and report serious reactions on a defined timeline. Get the process wrong, and you risk compliance findings during an inspection. This guide explains what you must report, when, and how to build a process that holds up.
Key Takeaways
- Adverse reaction reporting is a mandatory post-market obligation for every licensed NHP, not an optional courtesy.
- Serious adverse reactions must be reported to Health Canada within 15 days of becoming aware of them.
- The product licence holder, not the contract manufacturer, owns the reporting duty by default.
- A documented intake, assessment, and reporting SOP is what an inspector looks for.
- Annual summary reports may be requested, so retain records for the full required period.
What NHP Adverse Reaction Reporting Means in Canada
NHP adverse reaction reporting in Canada falls under the Natural Health Products Regulations, which treat post-market safety as seriously as pre-market licensing. An adverse reaction is a harmful and unintended response to a product at normal use. A serious adverse reaction is one that requires hospitalization, causes a congenital malformation, results in persistent disability, is life-threatening, or ends in death.
Here is what that means in practice: every licensed product carries an ongoing duty to watch for these events. The obligation does not end when the product licence is issued. Instead, it runs for the entire commercial life of the product.
Worth understanding before you proceed: this duty sits alongside your other regulatory commitments. If you are still mapping those out, this overview of Health Canada NHP compliance covers the wider framework that adverse reaction reporting fits into.
Who Must Report, and on What Timeline
The product licence holder owns the reporting obligation. In most contract manufacturing arrangements, that is the brand, not the manufacturer, though your agreement should state this explicitly. As a result, brand owners need a process in place before the first unit ships.
The timelines are specific. Brand owners must report serious adverse reactions that occur inside Canada to Health Canada within 15 days of becoming aware of them. Serious unexpected reactions from outside Canada follow the same 15-day window. In addition, Health Canada can request an annual summary report that reviews all reactions received during the year and flags any change in the product's risk profile.
This is where most brands run into trouble. They assume the manufacturer handles reporting automatically, when in fact the licence holder remains accountable. Clarify the division of responsibility in writing, and confirm who maintains the safety records.
Building a Compliant NHP Adverse Reaction Reporting Process
A compliant approach to NHP adverse reaction reporting in Canada rests on three repeatable steps: intake, assessment, and submission. First, capture every complaint through a single channel, whether it arrives by phone, email, or retailer. Second, assess each report against the seriousness criteria so you know which timeline applies. Third, submit qualifying reports to Health Canada through the Canada Vigilance Program.
Document each step in a standard operating procedure. An inspector will want to see that your intake is consistent, your assessment is defensible, and your submissions are on time. Specifically, retain the original complaint, your seriousness assessment, and proof of the date you became aware.
The practical implication: treat this as an operational system, not a one-off task. Records should be retained for the period required under the regulations, which aligns with the documentation discipline covered in this guide to batch records and NHP documentation.
How a Manufacturing Partner Fits In
While the licence holder owns reporting, a capable manufacturing partner supports the process. Good batch records let a brand trace a reported reaction back to a specific lot quickly, which sharpens the assessment and any potential recall decision. Clear product specifications also help a brand judge whether a reaction reflects a genuine safety signal or a misuse pattern.
Choosing a Canadian partner that understands these post-market obligations saves friction later. If you are evaluating manufacturers, the Perfect Herbs manufacturing services page covers available formats and capabilities, and you can always reach out for a quote to discuss your specific program.
Published: June 29, 2026